Eledon Pharmaceuticals, Inc.
ELDN
$3.88
-$0.02-0.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 133.34M | 93.40M | 107.57M | 124.88M | 140.18M |
| Total Receivables | 514.00K | 753.00K | 705.00K | 761.00K | 625.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.83M | 2.13M | 3.12M | 2.02M | 2.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.00K | 14.00K | 10.00K | 55.00K | 104.00K |
| Total Current Assets | 135.69M | 96.30M | 111.40M | 127.72M | 143.73M |
|
|
|||||
| Total Current Assets | 135.69M | 96.30M | 111.40M | 127.72M | 143.73M |
| Net Property, Plant & Equipment | 613.00K | 694.00K | 773.00K | 850.00K | 926.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 32.39M | 32.39M | 32.39M | 32.39M | 32.39M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 322.00K | 476.00K | 346.00K | 354.00K | 363.00K |
| Total Assets | 169.01M | 129.86M | 144.91M | 161.31M | 177.41M |
|
|
|||||
| Total Accounts Payable | 3.63M | 4.63M | 5.83M | 2.90M | 5.83M |
| Total Accrued Expenses | 14.36M | 9.32M | 7.55M | 5.96M | 5.43M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 358.00K | 346.00K | 336.00K | 325.00K | 314.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 18.34M | 14.30M | 13.72M | 9.19M | 11.58M |
|
|
|||||
| Total Current Liabilities | 18.34M | 14.30M | 13.72M | 9.19M | 11.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 283.00K | 376.00K | 467.00K | 555.00K | 640.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.60M | 24.13M | 24.70M | 36.99M | 47.05M |
| Total Liabilities | 32.23M | 38.80M | 38.88M | 46.73M | 59.27M |
|
|
|||||
| Common Stock & APIC | 537.96M | 481.80M | 479.37M | 476.68M | 473.70M |
| Retained Earnings | -401.20M | -390.76M | -373.30M | -362.08M | -355.59M |
| Treasury Stock & Other | 24.00K | 9.00K | -48.00K | -18.00K | 26.00K |
| Total Common Equity | 136.78M | 91.05M | 106.03M | 114.58M | 118.14M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 136.78M | 91.05M | 106.03M | 114.58M | 118.14M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 136.78M | 91.05M | 106.03M | 114.58M | 118.14M |
|
|
|||||